KR20160029969A - Virucidal composition containing natural products for avian inflenza virus - Google Patents

Virucidal composition containing natural products for avian inflenza virus Download PDF

Info

Publication number
KR20160029969A
KR20160029969A KR1020140119191A KR20140119191A KR20160029969A KR 20160029969 A KR20160029969 A KR 20160029969A KR 1020140119191 A KR1020140119191 A KR 1020140119191A KR 20140119191 A KR20140119191 A KR 20140119191A KR 20160029969 A KR20160029969 A KR 20160029969A
Authority
KR
South Korea
Prior art keywords
virus
weight
extract
citric acid
parts
Prior art date
Application number
KR1020140119191A
Other languages
Korean (ko)
Other versions
KR101647323B1 (en
Inventor
이후장
이수응
Original Assignee
경상대학교산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 경상대학교산학협력단 filed Critical 경상대학교산학협력단
Priority to KR1020140119191A priority Critical patent/KR101647323B1/en
Publication of KR20160029969A publication Critical patent/KR20160029969A/en
Application granted granted Critical
Publication of KR101647323B1 publication Critical patent/KR101647323B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A01N65/08Magnoliopsida [dicotyledons]
    • A01N65/34Rosaceae [Rose family], e.g. strawberry, hawthorn, plum, cherry, peach, apricot or almond
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A01N65/08Magnoliopsida [dicotyledons]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Agronomy & Crop Science (AREA)
  • Microbiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Provided is an antiviral disinfectant composition which is eco-friendly and safe to domestic animals since a composite extract of medicinal herbal ingredients and a natural medicinal mixture are used. To this end, the composition comprises as active ingredients: an extract of natural medicinal herbal ingredients composed of Arimonia pilosa L., Cmmelina communis, and Sutellaria baicalensis; citric acid; and bamboo vinegar.

Description

천연물을 함유하는 조류인플루엔자바이러스 살바이러스 조성물{Virucidal composition containing natural products for avian inflenza virus}[0001] The present invention relates to an avian influenza virus,

본 발명은 살바이러스 조성물에 관한 것으로서, 더 상세하게는 천연물을 함유하는 조류인플루엔자바이러스 살바이러스 조성물에 관한 것이다.FIELD OF THE INVENTION The present invention relates to virucidal compositions, and more particularly to avian influenza virus antiviral compositions containing natural products.

조류인플루엔자(avian influenza, AI)는 양계 및 오리 산업에 있어서 막대한 경제적 손실을 유발하는 가장 중요한 질환으로서, 원인균은 AI 바이러스이다. 현재, AI의 예방을 위한 백신은 개발되어 있지 않은 상태이며, 개발된다 하더라도 바이러스의 특성상 변이가 심하여 명확한 예방효과를 나타내기에는 많은 문제점이 있다. 백신이 개발되어 있지 않은 상태에서, AI의 발생예방이 매우 중요하다. 최근, 고병원성 AI가 우리나라에서에 발생되었으며, 기후온난화와 함께 AI의 발생 가능성은 점차로 증가하고 있다. The avian influenza (AI) is the most important disease causing great economic loss in the poultry and duck industries. The causative organism is the AI virus. At present, a vaccine for the prevention of AI has not been developed yet, and even if it is developed, there are many problems to exhibit a clear preventive effect due to a large variation due to the nature of the virus. In the absence of vaccine development, prevention of AI outbreaks is very important. In recent years, highly pathogenic AI has occurred in Korea, and the possibility of AI is increasing with climate warming.

대한민국 공개특허 제2013-0083585호는 유기 및 무기물질들 간의 조합비를 조절하여 내동결성, 소독 및 살균효능을 나타내는 소독약 조성물을 개시하고 있다. Korean Patent Laid-Open Publication No. 2013-0083585 discloses a disinfectant composition which exhibits anti-cohesion, disinfection and sterilizing effects by controlling the combination ratio between organic and inorganic materials.

그러나, 종래의 소독제 조성물은 화학적 합성에 의해 제조되어 가축 및 환경에 악영향을 미칠 수 있어 가축에 보다 안전하고, 친환경적인 소독제의 개발이 절실한 상황이다.However, the conventional disinfectant composition is produced by chemical synthesis, which may adversely affect livestock and the environment. Therefore, it is inevitable to develop safer and environmentally friendly disinfectants for livestock.

본 발명은 상기와 같은 문제점을 포함하여 여러 문제점들을 해결하기 위한 것으로서, 천연물을 이용하여 조류인플루인자 예방 및 가축의 세균성바이러스성 질병 예방용 소독제를 제공하는 것을 목적으로 한다. 그러나 이러한 과제는 예시적인 것으로, 이에 의해 본 발명의 범위가 한정되는 것은 아니다.Disclosure of Invention Technical Problem [8] Accordingly, the present invention has been made to solve the above-mentioned problems, and it is an object of the present invention to provide a disinfectant for preventing avian influenza and preventing bacterial viral diseases in domestic animals using natural products. However, these problems are exemplary and do not limit the scope of the present invention.

본 발명은 일 관점에 따르면, 선학초(Arimonia pilosa L.), 압척초(Cmmelina communis) 및 황금(Sutellaria baicalensis)으로 구성되는 천연 한방약재의 추출물, 구연산(citric acid) 및 죽초액(bamboo vinegar)을 유효성분으로 함유하는, 살균 및 살바이러스 조성물이 제공된다. According to one aspect of the present invention, there is provided a method for producing a natural herbal medicine extract, citric acid and bamboo vinegar comprising Arimonia pilosa L. , Cmmelina communis and Sutellaria baicalensis , ≪ RTI ID = 0.0 > antimicrobial < / RTI >

본 발명의 다른 일 관점에 따르면, 선학초(Agrimonia pilosa L.), 압척초(Commelina communis) 및 황금(Scutellaria baicalensis)으로 구성되는 천연 한방약재 분말을 혼합하고 물, C1 내지 C4의 저급알코올 또는 상기 저급알코올의 수용액을 첨가하여 복합추출물을 추출하는 추출단계; 및 상기 추출분말과 구연산 및 죽초액을 배합하고 용해시키는 단계를 포함하는, 살균 및 살바이러스 조성물 제조방법이 제공된다.According to another aspect of the present invention, there is provided a pharmaceutical composition comprising a mixture of natural herbal medicine powder consisting of Agrimonia pilosa L. , Commelina communis and gold ( Scutellaria baicalensis ), water, C1 to C4 lower alcohol, An extraction step of extracting a complex extract by adding an aqueous solution of alcohol; And a step of blending and dissolving the extract powder with citric acid and bamboo shoots.

상기한 바와 같이 이루어진 본 발명의 일 실시예에 따르면, 한방약재인 선학초, 압척초 및 황금의 추출분말과 구연산을 배합하여, 친환경적이면서 조류인플루엔자바이러스에 대해 효과적인 소독 효과를 구현할 수 있다. 물론 이러한 효과에 의해 본 발명의 범위가 한정되는 것은 아니다.According to one embodiment of the present invention as described above, it is possible to realize an effective disinfection effect on environmentally-friendly avian influenza virus by blending citric acid, sunflower seeds, acacia var. Of course, the scope of the present invention is not limited by these effects.

용어의 정의:Definition of Terms:

본 문서에서 사용되는 "죽초액(bamboo vinegar)"은 대나무를 밀폐된 공간에서 탄화시켜 숯을 제조하는 과정에서 생성되는 기체(수증기와 연기)를 냉각시켜 얻어진 갈색의 액체를 용기에 밀폐하여 냉암소에서 3∼6개월간 정치시키면 세 개의 층으로 분리되는데 일반적으로 중간층을 말한다. 죽초액의 주요성분으로 아세트산과 기타 유기산 외에도 알코올류, 페놀류, 카보닐류, 중성화합물 및 염기성 성분 등 270여종의 성분을 함유하고 있으며 간의 해독작용, 간 기능회복 효과, 혈당강하 효과, 숙취해소와 피로회복 효과, 항균 및 항바이러스 효과 등을 갖고 있는 것으로 보고되어 있다. As used in this document, "bamboo vinegar" is a method of carbonizing bamboo in a closed space, cooling the gas (water vapor and smoke) produced during the process of producing charcoal, When left to stand for 3 to 6 months, it is divided into three layers, usually the middle layer. It contains 270 kinds of ingredients such as alcohols, phenols, carbonyls, neutral compounds and basic components in addition to acetic acid and other organic acids as main components of bamboo smoke extract. It has liver detoxification effect, liver function recovery effect, blood glucose lowering effect, hangover resolution and fatigue recovery Effect, antimicrobial and antiviral effect, and the like.

본 문서에서 사용되는 "선학초(Agrimonia pilosa ledeb)"는 장미과에 속하는 다년생 숙근초로서 용아초, 황아초, 지선초 및 짚신나물 등으로 부르기도 한다. 선학초의 추출물은 예부터 민간요법, 녹즙 등으로 널리 이용되어 왔고, 폐암, 간암, 식도암, 종양, 통증제거, 지사, 토혈, 혈뇨 및 자궁출혈 등에 치료 약물로서 널리 이용되어 왔다. 한의학에서는 수렴작용이 강하여 지사제 및 지혈제로 사용되어 왔다. 주요 성분으로는 전초에 아그리모닌(agrimonin), 아그리모놀리드(agrimonolide), 토멘트산(tormentic acid) 및 엘라그산(ellagic acid) 등이 있고, 잎과 줄기에는 luteolin-7-glucoside가 함유되어 있으며, 최근 연구에서는 항바이러스 효과, 당뇨치료 효과, 혈관이완 효과, 항균효과, 항산화 및 항암활성 등이 있는 것으로 보고되었다.As used herein, " Agrimonia pilosa ledeb "is a perennial herbaceous perennial belonging to the Rosaceae family. The extracts of Seonghak-cho have been widely used as folk remedies, green juice, etc. and have been widely used as therapeutic agents for lung cancer, liver cancer, esophageal cancer, tumor, pain relief, branching, hematemesis, hematuria and uterine bleeding. In oriental medicine, it has strong convergence action and has been used as a medicinal and hemostatic agent. Agrimonin, agrimonolide, tormentic acid and ellagic acid, and luteolin-7-glucoside are contained in leaves and stems. The main components are agrimonin, agrimonolide, tormentic acid and ellagic acid. . Recent studies have reported antiviral, diabetic, vasodilatory, antimicrobial, antioxidant and anticancer activities.

본 문서에서 사용되는 "압척초(Commelina communis)"는 닭의장풀과에 속하며, 길가나 풀밭 등에서 흔히 볼 수 있는 일년생 풀로서 닭의장풀, 닭의 밑씻개, 닭개비 및 달개비 등으로 불린다. 압척초는 예로부터 해열, 해독, 이뇨 등에 사용되었으며, 감기로 인한 열, 황달, 간염, 인후염 및 당뇨병 등의 질환에도 효능이 있는 것으로 알려져 있다. 압척초의 전초에는 알칼로이드 성분인 1-carbomethoxy-β-carboline, 노르하르만(norharman)및 하르만(harman) 등이 있으며, 혈압강화작용, 항균효과, 항바이러스 효과 및 항산화 효과 등이 있는 것으로 보고되고 있다.As used in this document, " Commelina communis " belongs to the genus Chironomidaceae and is commonly known as a year-old grass common in roads and grasses. It is also called Chicken foxtail, Chicken underwoven, Chicken goby, and Starbuck. It has been used for antipyretic, detoxification, diuretic and has been known to be effective for diseases such as fever, jaundice, hepatitis, sore throat and diabetes caused by a cold. 1-carbomethoxy-β-carboline, norharman, and harman, which are alkaloid components, are reported to have blood pressure enhancing action, antimicrobial effect, antiviral effect and antioxidant effect.

본 문서에서 사용되는 "황금(Scutellaria baicalensis)"은 꿀풀과에 속하는 여러해살이풀로 예로부터 고열, 기침, 변비 및 황달 등의 치료에 사용되었으며, 뿌리에는 베카레인(baicalein), 바이칼린(baicalin), 우호닌(wohonin), 우고닌(wogonin), wogonin 7-O-glucuronide, 오록실린(oroxylin A), oroxylin A 7-O-glucuronide, 노베카레인(nobaicalein), 시토스테롤(sitosterol) 및 아피게닌(apigenin) 및 크리신(chrysin) 등이 함유되어 있는 것으로 알려져 있다. 황금은 항균 작용, 항바이러스 작용, 간보호 작용, 항암 효과 및 항염증 효과 등이 있는 것으로 보고되어 있다.As used herein, "Golden ( Scutellaria baicalensis )" is a perennial herb that belongs to the family Lamiaceae, and has long been used for the treatment of high fever, cough, constipation and jaundice. The roots include baicalein, baicalin, O-glucuronide, nobaicalein, sitosterol, and apigenin (also known as norepinephrine), wohonin, wogonin, wogonin 7-O-glucuronide, oroxylin A, apigenin) and chrysin (chrysin). Gold has been reported to have antibacterial, antiviral, liver protective, anti-cancer and anti-inflammatory effects.

본 문서에서 사용되는 "구연산(citric acid)"은 귤속 과일에서 주로 발견되는 약한 유기산으로 무색투명한 분말이다. 구연산은 천연보존제이며, 음식이나 음료수에 산성 또는 신 맛을 내기위한 산미제로 사용된다. 구연산은 체내의 탄수화물의 대사를 촉진시키고, 체내 노폐물의 배출효과가 있으며 항균·항진균 효과, 항바이러스 효과, 혈압강하 효과 및 피로회복 효과 등이 있는 것으로 보고되어 있다.As used herein, "citric acid" is a weak organic acid found predominantly in citrus fruits and is a colorless transparent powder. Citric acid is a natural preservative and is used as an acidifier to give acid or sour taste to food or beverage. Citric acid promotes the metabolism of carbohydrates in the body, has the effect of excretion of waste products in the body, and has been reported to have antibacterial and antifungal effects, antiviral effects, blood pressure lowering effects and fatigue recovery effects.

발명의 상세한 설명:DETAILED DESCRIPTION OF THE INVENTION [

본 발명은 일관점에 따르면, 선학초(Arimonia pilosa L.), 압척초(Cmmelina communis) 및 황금(Sutellaria baicalensis)으로 구성되는 천연 한방약재의 추출물, 구연산(citric acid) 및 죽초액(bamboo vinegar)을 유효성분으로 함유하는, 살균 및 살바이러스 조성물이 제공된다. According to one aspect of the present invention, there is provided a method for producing a natural herbal medicine extract, citric acid and bamboo vinegar comprising Arimonia pilosa L. , Cmmelina communis and Sutellaria baicalensis , ≪ RTI ID = 0.0 > antimicrobial < / RTI >

상기 조성물에 있어서, 상기 천연 한방약재는 선학초 20 중량부, 압척초 1~3 중량부, 황금 1~3 중량부로 구성될 수 있고, 상기 조성물은 상기 천연 한방약재의 추출물 1 중량부에 대하여 구연산 0.5~2 중량부 및 죽초액 6~10 중량부를 포함할 수 있다. In the composition, the natural herbal medicine may be composed of 20 parts by weight of Seokjak, 1 ~ 3 parts by weight of Angelica keiskei, 1 ~ 3 parts by weight of gold, And 2 to 6 parts by weight of a bamboo charcoal.

상기 조성물에 있어서, 상기 바이러스는 가금류 또는 가축으로부터 유래하는 바이러스 일 수 있다. 상기 가금류 유래의 바이러스는 뉴캐슬병바이러스(newcastle disease virus) 또는 조류인플루엔자바이러스(AI)일 수 있다. 상기 조류인플루엔자바이러스는 H5N1 또는 H9N2 형의 조류인플루엔자 바이러스 일 수 있다. In the above composition, the virus may be a virus derived from poultry or livestock. The poultry-derived virus may be a newcastle disease virus or avian influenza virus (AI). The avian influenza virus may be avian influenza virus of the H5N1 or H9N2 type.

상기 가축 유래의 바이러스는 뉴캐슬 바이러스(newcastle disease virus), 돼지 콜레라 바이러스(hog cholera virus), 신종플루(H1N1) 바이러스 또는 구제역 바이러스(FMDV)일 수 있다. The livestock-derived virus may be a newcastle disease virus, a hog cholera virus, a H1N1 virus or FMDV virus.

상기 조성물에 있어서, 상기 균은 살모넬라균, 브루셀라균, 대장균, 파스튜렐라균 또는 포도상구균일 수 있다. In the composition, the bacterium may be Salmonella, Brucella, Escherichia coli, Pasteurella or Staphylococcus.

본 발명의 다른 일 관점에 따르면, 선학초(Agrimonia pilosa L.), 압척초(Commelina communis) 및 황금(Scutellaria baicalensis)으로 구성되는 천연 한방약재 분말을 혼합하고 물, C1 내지 C4의 저급알코올 또는 상기 저급알코올의 수용액을 첨가하여 복합추출물을 추출하는 추출단계; 및 상기 추출분말과 구연산 및 죽초액을 배합하고 용해시키는 단계를 포함하는, 살균 및 살바이러스 조성물 제조방법이 제공된다.According to another aspect of the present invention, there is provided a pharmaceutical composition comprising a mixture of natural herbal medicine powder consisting of Agrimonia pilosa L. , Commelina communis and gold ( Scutellaria baicalensis ), water, C1 to C4 lower alcohol, An extraction step of extracting a complex extract by adding an aqueous solution of alcohol; And a step of blending and dissolving the extract powder with citric acid and bamboo shoots.

이하, 실시예를 통하여 본 발명을 더 상세히 설명한다. 그러나 본 발명은 이하에서 개시되는 실시예에 한정되는 것이 아니라 서로 다른 다양한 형태로 구현될 수 있는 것으로, 이하의 실시예는 본 발명의 개시가 완전하도록 하며, 통상의 지식을 가진 자에게 발명의 범주를 완전하게 알려주기 위해 제공되는 것이다. Hereinafter, the present invention will be described in more detail by way of examples. It should be understood, however, that the invention is not limited to the disclosed embodiments, but may be embodied in many different forms and should not be construed as limited to the embodiments set forth herein. Rather, these embodiments are provided so that this disclosure will be thorough and complete, Is provided to fully inform the user.

실시예 1: 조류인플루엔자 바이러스 살바이러스 조성물 제조Example 1: Preparation of avian influenza virus viral composition

본 발명은 한방약재인 선학초, 압척초, 황금과 구연산, 죽초액을 이용하여 살균 및 살바이러스 조성물을 제조하였다.The present invention provides a sterilizing and virucidal composition using sunflower seeds, apricot herb, gold and citric acid, and bamboo shoots.

구체적으로, 한방약재인 선학초, 압척초 및 황금을 분말화하여 각각을 10:1:1의 비율로 혼합한 뒤 메탄올로 상온에서 24시간 동안 진탕추출하였다. 상기 천연물합제의 상층액을 감압농축시켜 동결건조한 추출분말과 구연산을 1:1로 배합하여, 20%가 되게 죽초액에 용해시켜, AI 바이러스 살바이러스 조성물을 확립하였다. 상기 조성물의 성분 및 함량을 하기 표 1에 표시하였다. Specifically, the medicinal herbs such as sunflower seeds, ginger powder, and gold were pulverized and mixed at a ratio of 10: 1: 1, followed by shaking with methanol at room temperature for 24 hours. The supernatant of the natural product mixture was concentrated under reduced pressure, lyophilized extract powder and citric acid were mixed at a ratio of 1: 1 and dissolved in a bamboo liquid to a concentration of 20% to establish an AI virus antiviral composition. The composition and contents of the composition are shown in Table 1 below.

성분ingredient 함량(g/L)Content (g / L) 천연물합제 추출물Extract of natural materials 100100 구연산Citric acid 100100 죽초액Bamboo flake 총부피 1 L에 맞춤Fit to total volume 1L

실시예 2: 조성물 소독제 대한 효력시험 방법Example 2: Effectiveness test for composition disinfectant

본 발명의 일 실시예 따라 제조한 AI 바이러스 살바이러스 조성물의 효력을 평가하기 위해 소독대상 병원체를 함유한 희석액과 소독제 희석액을 혼합한 후, 처리구에 처리하였다. To evaluate the efficacy of the AI virus antiviral composition prepared according to one embodiment of the present invention, a diluent containing a pathogen to be disinfected and a disinfectant diluent were mixed and then treated with the treatment.

2-1: 평가 기준2-1: Evaluation Criteria

소독대상의 유기물 함량에 따라서 유기물이 많은 소독대상은 발판소독조, 축사바닥, 오물, 사체, 농장차량 및 운반용구 등으로 분류하며, 유기물이 적은 소독대상은 축사공간, 축체표면, 축사기구 및 일반차량 등으로 분류하였다. 또한 유효배수의 평가는 병원체 대조군의 바이러스 감염역가에 비하여 소독제 처리군의 바이러스 감염역가가 104 EID50 이상 불활성화가 인정되는 희석농도를 유효농도로 하며, 최종 유효 희석배수의 결정은 각각의 3 반복 시험결과를 상용대수로 환산하여, 20% 오차범위 내로 들어오는 결과 값의 중위수(median)로 하였다.According to the organic matter content of the object to be disinfected, the object to be disinfected is classified into a disinfection tank, floor, dirt, carcass, farm vehicle and transportation equipment, and the disinfection object with less organic material is classified into a housing space, . In addition, the effluent concentration was determined as the effective concentration of the dilution concentration at which the viral infectivity of the disinfectant treated group was inactivated by 10 4 EID 50 or more, compared with the viral infection activity of the pathogen control group. The results of the repeated test were converted into the logarithm of the common logarithm, and the result was regarded as the median of the results which were within the 20% error range.

2-2: 시험 바이러스2-2: Test virus

본 발명의 일 실시예 따라 제조된 소독제 조성물의 살바이러스 효력을 평가하기 위해 농림축산검역본부에서 분양받은 조류인플루엔자 바이러스 H9N2(MS96 strain)을 시험에 공시하였다. 상기 바이러스주를 10일령의 AIV 무항체 SPF 발육란의 요막강내에 접종하여, 계대 배양하였고 증식된 바이러스의 활력이 최대인 시점(바이러스 역가 107 EID50/mL 이상)에 채독하여 시험에 공시하였다.To evaluate the virucidal efficacy of the disinfectant composition prepared according to one embodiment of the present invention, the avian influenza virus H9N2 (MS96 strain) prevalent in the agriculture, forestry and livestock quarantine division was disclosed in the test. The virus strain was inoculated into the umbilical cord of 10-day-old AIV non-antibody SPF developmental cattle, subcultured, and tested at the time when the vital capacity of the proliferated virus was maximal (virus titer of 10 7 EID 50 / mL or more).

2-3: 소독제의 희석 및 처리 과정2-3: Dilution and disinfection of disinfectants

본 발명의 일 실시예에 따라 제조된 소독제의 희석은 대상 처리구에 맞게 경수 및 유기물 희석액(5% 우태아혈청 함유)으로 희석하였으며, 이때 처리구에 따라 다양한 희석배수를 적용하여 희석하였다. 상기 희석배수는 하기 표 2에 표시하였다. Dilution of disinfectant prepared according to one embodiment of the present invention was diluted with water and organic diluent (containing 5% fetal bovine serum) in accordance with the target treatment, and diluted with various dilutions according to the treatments. The dilution factors are shown in Table 2 below.

조건Condition 희석배수Dilution factor 처리구 1Treatment 1 1/1,200, 1/1,350, 1/1,500, 1/1,650, 1/1,800, 1/1,9501 / 1,200, 1 / 1,350, 1 / 1,500, 1 / 1,650, 1 / 1,800, 처리구 2Treatment 2 1/800, 1/900, 1/1,000, 1/1,100, 1/1,200, 1/1,3001/800, 1/900, 1 / 1,000, 1 / 1,100, 1 / 1,200, 1 / 1,300

상기 소독제는 바이러스가 존재하는 요막강액 1.0 mL를 19 mL의 처리구에 맞게 경수 및 유기물 희석액(5% 우태아혈청)에 혼합한 후, 1분 간격으로 2.5 mL씩을 취하여 동량의 소독제 희석액이 들어 있는 시험관에 혼합하였다. 상기 혼합액을 4℃에서 정확히 30분간 반응시키고 반응 중 10분마다 혼합하였으며 처리구 3은 대조구로 소독액 대신에 경수를 사용하였다. 경수는 증류수 1 리터에 CaCl2 0.305 g 과 MgCl2·6H2O 0.139 g을 녹인 뒤, 고압 멸균하여 4℃에 보관하였다. 조성물 소독제의 유기물 희석액은 5% 우태아혈청이 함유되도록 멸균된 경수에 용해하여 사용하였다. 조성물 소독제의 반응이 종료된 후, 조성물 소독제의 효능을 중화시키기 위해 37℃에서 즉시 조성물 소독액 1분량에 비동화된 10% 우태아혈청 함유 인산완충식염수(pH 7.2) 1분량을 혼합하여 중화시켰다. 처리구 3인 병원체 대조군은 경수조건에서 소독제 없이 실험하고 상기'중화반응'단계에서 병원체의 역가가 ml 당 2×105 TCID50 이상 여부를 확인하였으며, 처리구 4인 독성대조군에서는 소독제에 의한 종란독성 발생 여부를 확인하였다. 상기 소독제의 효력시험 평가를 위한 처리구를 하기 표 3에 표시하였다. The disinfectant was prepared by mixing 1.0 mL of the uremic lavage fluid containing the virus into the hard water and organic diluent (5% fetal bovine serum) in a ratio of 19 mL to 2.5 mL each at 1 minute intervals, And mixed in a test tube. The mixed solution was reacted at 4 ° C for exactly 30 minutes and mixed every 10 minutes during the reaction. Treatment water 3 was replaced with hard water in place of disinfectant as a control. The hard water was prepared by dissolving 0.305 g of CaCl 2 and 0.139 g of MgCl 2 .6H 2 O in 1 liter of distilled water, sterilized by high pressure and stored at 4 ° C. The organic dilution of the composition disinfectant was dissolved in sterilized hard water to contain 5% fetal bovine serum. After the reaction of the composition disinfectant was terminated, one part of phosphate buffered saline (pH 7.2) containing 10% fetal bovine serum immobilized at 1 minute of the composition disinfectant solution was neutralized at 37 ° C to neutralize the effect of the composition disinfectant immediately. In the 'Neutralization Reaction' stage, the titer of the pathogen was found to be 2 × 10 5 TCID 50 or more per ml. In the toxic control group of 4 treatments, the toxicity of the disinfectant Respectively. The treatments for the efficacy test evaluation of the disinfectants are shown in Table 3 below.

처리구Treatment 경수Water 유기물Organic matter 소독제disinfectant 비고Remarks 1(유기물 저)1 (organic matter low) ++ -- ++ 경수조건Hard water condition 2(유기물 고)2 (organic matter) ++ ++ ++ 유기물/경수조건Organic / light water conditions 3(병원체 대조)3 (Pathogen contrast) ++ -- -- 처리구 1, 2의 대조 Control of treatments 1 and 2 4(독성 대조)4 (Toxic contrast) ++ -- ++ 처리구 3의 대조Control of treatment 3

2-4: 바이러스 증식여부 판정2-4: Determination of Virus Proliferation

상기 중화액에 인산완충식염수를 사용하여 원액, 10-1, 10-2, 10-3, 10-4, 10-5 및 10-6 으로 희석한 뒤 0.2 ml을 희석배수당 5개의 10일 발육란의 요막강내에 접종하고, 37℃의 부화기내에서 5일간 배양하였다. 이후 매일 검란을 실시하였으며, 접종 후 24시간 이내에 죽은 발육란은 사고사로 간주하고 시험성적에서 제외하였다. 상기 접종한 모든 발육란으로부터 요막강액을 채취하여 동량의 닭 혈구(1%)를 사용한 평판 혈구응집반응에 의해 감염 여부를 판정하였고 바이러스의 함유량 계산은 하기 수학식 1의 Kaerber method를 이용하였다. Stock solution with a phosphate buffered saline to the neutralized liquid, 10 -1, 10 -2, 10 -3, 10 -4, 10 -5 and 10 -6 dilution of 0.2 ml after a 5-fold allowance 10 days balyukran diluted with , And cultured in an incubator at 37 캜 for 5 days. After that, the dogs were sacrificed every day and the dead cells within 24 hours after vaccination were regarded as accidents and excluded from the test results. The lumenal fluid was collected from all the inoculated dogs, and the infection was judged by the plate hemocyte aggregation reaction using the same amount of chicken blood (1%). The content of virus was calculated by the Kaerber method of Equation 1 below.

Figure pat00001
Figure pat00001

(L1, 조사된 가장 낮은 희석배수의 로그값; L, 희석배수 사이의 간격에 대한 로그값; S, 각 희석배수에서의 사멸율의 합) (L 1 , the logarithm of the lowest dilution factor examined; L, the logarithm of the interval between dilution factors; S, the sum of the death rates at each dilution)

실시예 3: 소독제 조성물의 살바이러스 효과Example 3: Viral viral effect of disinfectant composition

본 발명의 일 실시예 따라 제조한 소독제 조성물을 다양한 희석배수에 따라 희석하고 실험조건 처리구에 처리하여 소독효력을 평가하였다. 조류인플루엔자바이러스는 대조군과 비교하여 병원체가 104 감소가 확인된 희석배수를 3회 반복시험을 실시하여, 그 중위수를 유효 희석배수 설정하였다.The disinfectant composition prepared according to one embodiment of the present invention was diluted according to various dilution waters and treated in the experimental conditions to evaluate the disinfecting effect. The avian influenza virus was tested in triplicate for a dilution factor of 10 4 reduction of pathogen in comparison with the control, and the median was set as the effective dilution factor.

3-1: 1차 시험결과3-1: First test result

소독대상 병원체를 함유한 경수 희석액과 유기물 희석액을 동량의 조성물 소독제 희석액과 혼합 후, 4℃에서 30분간 처리하여 효력을 평가 한 결과, 처리구 1에서는 1/1,500 희석배수 조건에서 로그 감소값이 4.0으로 확인되었으며 처리구 2에서는 1/1,000 희석배수 조건에서는 4.1로 확인되었다. 상기 1차 시험결과를 하기 표 4에 표시하였다. As a result of evaluating the efficacy of the water-diluted solution containing the pathogen to be disinfected and the diluted organic solution with the same amount of the composition disinfectant diluent at 4 ° C for 30 minutes, the log reduction value was 4.0 at 1 / 1,500 dilution And in treatment 2, it was 4.1 in 1 / 1,000 dilution. The results of the above primary test are shown in Table 4 below.

처리구
Treatment
소독제 희석배수
Disinfectant dilution
중화액 희석배수 (양성수/총접종수)
Neutral liquid dilution drainage (positive water / total inoculated water)
EID50
EID 50
로그
감소값
Log
Decrease value
10-1 10 -1 10-2 10 -2 10-3 10 -3 10-4 10 -4 10-5 10 -5 10-6 10 -6 처리구 1




Treatment 1




1/1,2001 / 1,200 0/50/5 0/50/5 0/50/5 0/50/5 0/50/5 0/50/5 ≤0.50.5 ≥5.8≥5.8
1/1,3501 / 1,350 2/52/5 1/51/5 0/50/5 0/50/5 0/50/5 0/50/5 1.11.1 4.34.3 1/1,5001 / 1,500 3/53/5 2/52/5 0/50/5 0/50/5 0/50/5 0/50/5 1.51.5 4.04.0 1/1,6501 / 1,650 4/54/5 3/53/5 2/52/5 1/51/5 0/50/5 0/50/5 2.52.5 3.43.4 1/1,8001 / 1,800 5/55/5 4/54/5 3/53/5 2/52/5 1/51/5 0/50/5 3.53.5 2.72.7 1/1,9501 / 1,950 5/55/5 5/55/5 5/55/5 3/53/5 2/52/5 1/51/5 4.74.7 1.81.8 처리구 2




Treatment 2




1/8001/800 0/50/5 0/50/5 0/50/5 0/50/5 0/50/5 0/50/5 ≤0.50.5 ≥5.8≥5.8
1/9001/900 1/51/5 0/50/5 0/50/5 0/50/5 0/50/5 0/50/5 0.70.7 5.15.1 1/1,0001 / 1,000 3/53/5 1/51/5 0/50/5 0/50/5 0/50/5 0/50/5 1.31.3 4.14.1 1/1,1001 / 1,100 3/53/5 2/52/5 1/51/5 0/50/5 0/50/5 0/50/5 2.12.1 3.53.5 1/1,2001 / 1,200 5/55/5 5/55/5 4/54/5 2/52/5 1/51/5 0/50/5 3.93.9 2.42.4 1/1,3001 / 1,300 5/55/5 5/55/5 5/55/5 3/53/5 2/52/5 1/51/5 4.74.7 1.81.8 처리구 3
(병원체대조)
Treatment 3
(Pathogen contrast)
5/55/5 5/55/5 5/55/5 5/55/5 5/55/5 4/54/5 6.36.3
처리구 4
(독성대조)
Treatment 4
(Toxic contrast)
0/50/5 0/50/5 0/50/5 0/50/5 0/50/5 0/50/5

3-2: 2차 시험결과3-2: Second test result

2차 시험에서는 처리구 1에서 1/1,350 희석배수 조건의 로그 감소값이 4.1으로 확인되었으며 처리구 2에서는 1/900 희석배수 조건은 4.3으로 확인되었다. 상기 2차 시험결과를 하기 표 5에 표시하였다. In the second test, the log reduction value of 1 / 1,350 dilution drainage conditions at treatment 1 was found to be 4.1, and the 1/900 dilution drainage condition at treatment 2 was found to be 4.3. The results of the secondary test are shown in Table 5 below.

처리구
Treatment
소독제 희석배수
Disinfectant dilution
중화액 희석배수 (양성수/총접종수)
Neutral liquid dilution drainage (positive water / total inoculated water)
EID50
EID 50
로그
감소값
Log
Decrease value
10-1 10 -1 10-2 10 -2 10-3 10 -3 10-4 10 -4 10-5 10 -5 10-6 10 -6 처리구 1




Treatment 1




1/1,2001 / 1,200 0/50/5 0/50/5 0/50/5 0/50/5 0/50/5 0/50/5 ≤0.50.5 ≥5.8≥5.8
1/1,3501 / 1,350 3/53/5 1/51/5 0/50/5 0/50/5 0/50/5 0/50/5 1.31.3 4.14.1 1/1,5001 / 1,500 3/53/5 2/52/5 1/51/5 0/50/5 0/50/5 0/50/5 1.71.7 3.83.8 1/1,6501 / 1,650 5/55/5 4/54/5 2/52/5 1/51/5 0/50/5 0/50/5 2.92.9 3.23.2 1/1,8001 / 1,800 5/55/5 4/54/5 3/53/5 1/51/5 0/50/5 0/50/5 3.13.1 3.13.1 1/1,9501 / 1,950 5/55/5 5/55/5 4/54/5 2/52/5 0/50/5 0/50/5 3.73.7 2.52.5 처리구 2




Treatment 2




1/8001/800 0/50/5 0/50/5 0/50/5 0/50/5 0/50/5 0/50/5 ≤0.50.5 ≥5.8≥5.8
1/9001/900 2/52/5 1/51/5 0/50/5 0/50/5 0/50/5 0/50/5 1.11.1 4.34.3 1/1,0001 / 1,000 3/53/5 1/51/5 0/50/5 0/50/5 0/50/5 0/50/5 1.71.7 3.83.8 1/1,1001 / 1,100 4/54/5 2/52/5 1/51/5 0/50/5 0/50/5 0/50/5 1.91.9 3.63.6 1/1,2001 / 1,200 5/55/5 5/55/5 3/53/5 2/52/5 1/51/5 0/50/5 3.73.7 2.52.5 1/1,3001 / 1,300 5/55/5 5/55/5 5/55/5 4/54/5 2/52/5 1/51/5 4.94.9 1.51.5 처리구 3
(병원체대조)
Treatment 3
(Pathogen contrast)
5/55/5 5/55/5 5/55/5 5/55/5 5/55/5 4/54/5 6.36.3
처리구 4
(독성대조)
Treatment 4
(Toxic contrast)
0/50/5 0/50/5 0/50/5 0/50/5 0/50/5 0/50/5

3-3: 3차 시험결과3-3: Third test result

마지막 3차 시험에서는 처리구 1에서 1/1,500 희석배수 조건의 로그 감소값이 4.3으로 확인되었으며 처리구 2에서는 1/1,000 희석배수 조건은 4.3로 확인되었다. 상기 3차 시험결과를 하기 표 6에 표시하였다. In the last tertiary test, the log reduction value of 1 / 1,500 dilution drainage condition was observed to be 4.3 in treatment 1, and the dilution drainage condition of 1 / 1,000 was 4.3 in treatment 2. The results of the third test are shown in Table 6 below.

처리구
Treatment
소독제 희석배수
Disinfectant dilution
중화액 희석배수 (양성수/총접종수)
Neutral liquid dilution drainage (positive water / total inoculated water)
EID50
EID 50
로그
감소값
Log
Decrease value
10-1 10 -1 10-2 10 -2 10-3 10 -3 10-4 10 -4 10-5 10 -5 10-6 10 -6 처리구 1




Treatment 1




1/1,2001 / 1,200 0/50/5 0/50/5 0/50/5 0/50/5 0/50/5 0/50/5 ≤0.50.5 ≥5.8≥5.8
1/1,3501 / 1,350 0/50/5 0/50/5 0/50/5 0/50/5 0/50/5 0/50/5 ≤0.50.5 ≥5.8≥5.8 1/1,5001 / 1,500 2/52/5 1/51/5 0/50/5 0/50/5 0/50/5 0/50/5 1.11.1 4.34.3 1/1,6501 / 1,650 4/54/5 2/52/5 0/50/5 0/50/5 0/50/5 0/50/5 1.71.7 3.83.8 1/1,8001 / 1,800 5/55/5 5/55/5 2/52/5 1/51/5 1/51/5 0/50/5 3.33.3 2.92.9 1/1,9501 / 1,950 5/55/5 5/55/5 4/54/5 3/53/5 1/51/5 0/50/5 4.14.1 2.02.0 처리구 2




Treatment 2




1/8001/800 0/50/5 0/50/5 0/50/5 0/50/5 0/50/5 0/50/5 ≤0.50.5 ≥5.8≥5.8
1/9001/900 0/50/5 0/50/5 0/50/5 0/50/5 0/50/5 0/50/5 ≤0.50.5 ≥5.8≥5.8 1/1,0001 / 1,000 2/52/5 1/51/5 0/50/5 0/50/5 0/50/5 0/50/5 1.11.1 4.34.3 1/1,1001 / 1,100 4/54/5 2/52/5 0/50/5 0/50/5 0/50/5 0/50/5 1.71.7 3.83.8 1/1,2001 / 1,200 5/55/5 5/55/5 4/54/5 2/52/5 0/50/5 0/50/5 3.73.7 2.22.2 1/1,3001 / 1,300 5/55/5 5/55/5 5/55/5 4/54/5 2/52/5 1/51/5 4.94.9 1.51.5 처리구 3
(병원체대조)
Treatment 3
(Pathogen contrast)
5/55/5 5/55/5 5/55/5 5/55/5 5/55/5 4/54/5 6.36.3
처리구 4
(독성대조)
Treatment 4
(Toxic contrast)
0/50/5 0/50/5 0/50/5 0/50/5 0/50/5 0/50/5

3-4: 시험 결과판정3-4: Test result judgment

본 발명의 일 실시예 따라 제조한 소독제 조성물의 효력을 평가하기 위해 3차에 걸쳐 반복 실시한 시험에서 조류인플루엔자바이러스는 대조군과 비교하여 병원체가 104 감소가 확인된 희석배수의 중위수를 유효 희석배수로 설정하였다. 그 결과, 처리구 1(유기물 저)의 희석배수의 중위수는 1/1,500으로 확인되었으며 처리구 2(유기물 고)의 희석배수의 중위수는 1/1,000로 나타났고 처리구 4에서는 종란독성이 발생하지 않았다. 상기 소독제 조성물의 희석배수에 따른 소독제 효력시험의 결과를 하기 표 7에 표시하였다. Avian influenza viruses are effective dilution multiple set the median of the dilution factor a compared to the control agents is confirmed 10 4 reduction in repeat conducted tests for three cars to estimate the one embodiment the effect of a disinfectant composition prepared according to the present invention Respectively. As a result, the median of the dilution factor of treatment 1 (organic matter low) was 1 / 1,500, the median of the dilution factor of treatment 2 (organic matter high) was 1 / 1,000 and no toxicity was observed in treatment 4. The results of the disinfectant efficacy test according to the dilution drainage of the disinfectant composition are shown in Table 7 below.

처리구Treatment 1차Primary 2차Secondary 3차Third 중위수Moderate number 처리구 1 (유기물 저) Treatment 1 (organic matter) 1/1,5001 / 1,500 1/1,3501 / 1,350 1/1,5001 / 1,500 1/1,5001 / 1,500 처리구 2 (유기물 고) Treatment 2 (organic matter) 1/1,0001 / 1,000 1/9001/900 1/1,0001 / 1,000 1/1,0001 / 1,000 처리구 3 (병원체대조) Treatment 3 (Pathogen contrast) ++ ++ ++ 처리구 4 (독성대조) Treatment 4 (Toxic contrast) -- -- --

+, 바이러스 역가 106 EID50/ml 이상이 확인되었음.+, Virus titer 10 6 EID 50 / ml or more was confirmed.

-, 종란독성이 발생하지 않음.-, no toxicity to the head.

또한, 상기 시험결과를 토대로 압척초, 황금, 선학초, 구연산 및 죽초액의 성분조성별 조류인플루엔자 바이스러스에 대한 살바이러스 효과를 극대화할 수 있는 권장희석배수를 결정하였다. 소독대상은 경수조건, 유기물조건, 축사공간과 같은 유기물이 적은 대상 및 축사 바닥과 같은 유기물이 많은 소독대상으로 분류하여 각 성분조성에 따라 희석배수를 달리하였다. 상기 성분조성별 권장희석배수표를 하기 표 8에 표시하였다. Based on the test results, the recommended dilution ratios were determined to maximize the virulence effect of avian influenza viresicles according to the constitutional composition of Akecho, Golden, Seokhyeok, Citric acid and Bamboo liquid. The disinfection objects were classified into disinfection objects with high organic matter such as hard water condition, organic material condition, house space such as house space and house floor, and the dilution ratio was varied according to each composition. The recommended dilution factor checks for each of the above component compositions are shown in Table 8 below.


소독
대상


Disinfection
object

권장희석배수
Recommended dilution
성분조성Composition A+E A + E B+EB + E C+EC + E A+B+EA + B + E A+C+EA + C + E B+C+EB + C + E A+B+DA + B + D A+C+DA + C + D B+C+DB + C + D A+B+C+EA + B + C + E A+B+C+DA + B + C + D A+B+C+D+EA + B + C + D + E 경수조건Hard water condition 1:2001: 200 1:2001: 200 1:201:20 1:5001: 500 1:2001: 200 1:2001: 200 1:8001: 800 1:4001: 400 1:4001: 400 1:1,0001: 1,000 1:1,2001: 1,200 1:1,5001: 1,500 유기물조건Organic matter condition 1:1001: 100 1:1001: 100 1:101:10 1:2501: 250 1:801:80 1:801:80 1:4001: 400 1:1501: 150 1:1501: 150 1:6001: 600 1:7001: 700 1:1,0001: 1,000 유기물Organic matter 축사공간 등Housing space etc. 1:2001: 200 1:2001: 200 1:201:20 1:5001: 500 1:2001: 200 1:2001: 200 1:8001: 800 1:4001: 400 1:4001: 400 1:1,0001: 1,000 1:1,2001: 1,200 1:1,5001: 1,500 유기물Organic matter 축사바닥 등House floor etc. 1:1001: 100 1:1001: 100 1:101:10 1:2501: 250 1:801:80 1:801:80 1:4001: 400 1:1501: 150 1:1501: 150 1:6001: 600 1:7001: 700 1:1,0001: 1,000

상기 결과들을 종합해보면, 한방재료인 선학초, 압척초 및 황금으로 혼합된 천연물합제 추출물에 구연산을 배합하고 죽초액에 용해시켜 제조한 소독제 조성물을 3차에 걸쳐 조류인플루엔자바이러스에 대한 효력시험을 실시한 결과, 경수조건(유기물 저)에서 1,500배, 유기물조건(유기물고)에서 1,000배 희석하여 사용할 경우, 조류인플루엔자바이러스에 대한 효과가 있는 것으로 확인되었으며, 본 조성물 1,000배 조건에서 세포독성이 없는 것으로 확인되었다. As a result of the above tests, the disinfectant composition prepared by mixing citric acid with citric acid, herbal extracts, and herb extracts mixed with gold, and dissolving citric acid in a bamboo shoot, was subjected to an efficacy test on avian influenza virus three times. As a result, It was confirmed that when the composition was diluted 1,500 times in the hard water condition (low organic matter) and 1,000 times in the organic condition (high organic matter), it was found to have an effect on avian influenza virus.

본 발명은 상술한 실시예를 참고로 설명되었으나 이는 예시적인 것에 불과하며, 당해 기술분야에서 통상의 지식을 가진 자라면 이로부터 다양한 변형 및 균등한 다른 실시예가 가능하다는 점을 이해할 것이다. 따라서 본 발명의 진정한 기술적 보호 범위는 첨부된 특허청구범위의 기술적 사상에 의하여 정해져야 할 것이다.
While the present invention has been particularly shown and described with reference to exemplary embodiments thereof, it is to be understood that the invention is not limited to the disclosed embodiments, but, on the contrary, is intended to cover various modifications and equivalent arrangements included within the spirit and scope of the appended claims. Accordingly, the true scope of the present invention should be determined by the technical idea of the appended claims.

Claims (9)

선학초(Arimonia pilosa L.), 압척초(Cmmelina communis) 및 황금(Sutellaria baicalensis)으로 구성되는 천연 한방약재의 추출물, 구연산(citric acid) 및 죽초액(bamboo vinegar)을 유효성분으로 함유하는, 살균 및 살바이러스 조성물.The present invention relates to an extract of natural herbal medicine consisting of Arimonia pilosa L. , Cmmelina communis and gold ( Sutellaria baicalensis ), citric acid and bamboo vinegar as active ingredients, Virus composition. 제 1항에 있어서,
상기 천연 한방약재는 선학초 20 중량부, 압척초 1~3 중량부, 황금 1~3 중량부를 포함하는, 살균 및 살바이러스 조성물.
The method according to claim 1,
Wherein the natural oriental medicinal herb comprises 20 parts by weight of sunflower seeds, 1 to 3 parts by weight of crustacea, and 1 to 3 parts by weight of gold.
제 1항에 있어서,
상기 조성물은 상기 천연 한방약재의 추출물 1 중량부에 대하여 구연산 0.5~2 중량부 및 죽초액 6~10 중량부를 포함하는, 살균 및 살바이러스 조성물.
The method according to claim 1,
Wherein the composition comprises 0.5 to 2 parts by weight of citric acid and 6 to 10 parts by weight of a bamboo shoot to 1 part by weight of the extract of the natural herbal medicine.
제 1항에 있어서,
상기 바이러스는 가금류 또는 가축으로부터 유래하는, 살균 및 살바이러스 조성물.
The method according to claim 1,
Wherein the virus is derived from poultry or livestock.
제 4항에 있어서,
상기 가금류 유래의 바이러스는 뉴캐슬바이러스(newcastle disease virus), 또는 조류인플루엔자바이러스(AI)인, 살균 및 살바이러스 조성물.
5. The method of claim 4,
Wherein the poultry-derived virus is a newcastle disease virus, or avian influenza virus (AI).
제 5항에 있어서,
상기 조류인플루엔자바이러스는 H5N1 또는 H9N2 형인, 살균 및 살바이러스 조성물.
6. The method of claim 5,
Wherein said avian influenza virus is H5N1 or H9N2 type.
제 4항에 있어서,
상기 가축 유래의 바이러스는 돼지 오제스키병 바이러스(Pseudorabies Virus), 돼지 콜레라 바이러스(hog cholera virus), 신종플루(H1N1) 바이러스, 또는 구제역 바이러스(FMDV)인, 살균 및 살바이러스 조성물.
5. The method of claim 4,
Wherein the livestock-derived virus is Pseudorabies virus, hog cholera virus, H1N1 virus, or foot-and-mouth disease virus (FMDV).
제 1항에 있어서,
상기 균은 살모넬라균, 브루셀라균, 대장균, 파스튜렐라균 또는 포도상구균인, 살균 및 살바이러스 조성물.
The method according to claim 1,
Wherein the fungus is Salmonella, Brucella, Escherichia coli, Pasteurella or Staphylococcus.
선학초(Agrimonia pilosa L.), 압척초(Commelina communis) 및 황금(Scutellaria baicalensis)로 구성되는 천연 한방약재 분말을 혼합하고 물, C1 내지 C4의 저급알코올 또는 상기 저급알코올의 수용액을 첨가하여 복합추출물을 추출하는 추출단계;
및 상기 추출분말과 구연산 및 죽초액을 배합하고 용해시키는 단계를 포함하는, 살균 및 살바이러스 조성물 제조방법.

A natural herbal medicine powder composed of Agrimonia pilosa L. , Commelina communis , and gold ( Scutellaria baicalensis ) is mixed and an aqueous solution of water, C1 to C4 lower alcohol or the lower alcohol is added thereto to prepare a complex extract An extracting step of extracting;
And mixing and dissolving the extract powder with citric acid and bamboo shoots.

KR1020140119191A 2014-09-05 2014-09-05 Virucidal composition containing natural products for avian inflenza virus KR101647323B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020140119191A KR101647323B1 (en) 2014-09-05 2014-09-05 Virucidal composition containing natural products for avian inflenza virus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020140119191A KR101647323B1 (en) 2014-09-05 2014-09-05 Virucidal composition containing natural products for avian inflenza virus

Publications (2)

Publication Number Publication Date
KR20160029969A true KR20160029969A (en) 2016-03-16
KR101647323B1 KR101647323B1 (en) 2016-08-11

Family

ID=55649786

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020140119191A KR101647323B1 (en) 2014-09-05 2014-09-05 Virucidal composition containing natural products for avian inflenza virus

Country Status (1)

Country Link
KR (1) KR101647323B1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101863267B1 (en) * 2017-09-05 2018-06-29 주식회사 바이오스톤 Disinfectant composition for controlling foot-and-mouth disease or avian influenza
WO2018214641A1 (en) * 2017-05-24 2018-11-29 江苏省农业科学院 Use of agrimonia pilosa extract in preparation of drug for removing plant virus in tomato plants
KR20210071816A (en) * 2019-12-06 2021-06-16 울산대학교 산학협력단 Organic-inorganic emulsion composition for deodorization and antibacterial agent and fibrous mat having the composition
CN115590873A (en) * 2022-10-31 2023-01-13 河南省农业科学院动物免疫学重点实验室(Cn) Application of baicalin in preparation of anti-pseudorabies virus medicine
WO2023008594A1 (en) * 2021-07-26 2023-02-02 에이피알지 주식회사 Composition for prevention or treatment of coronavirus (sars-cov-2) infection, comprising agrimonia pilosa extract as active ingredient

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040010390A (en) * 2002-07-26 2004-01-31 가부시끼가이샤 롯데 Anti-influenza viral agent, the composition and the food containing the same
KR101164515B1 (en) * 2009-11-05 2012-07-11 한국 한의학 연구원 Composition for Prevention or Treatment of Disease Originated from Influenza Virus
KR20130095010A (en) * 2012-02-17 2013-08-27 재단법인 산청한방약초연구소 Natural anti-herpes virus agent and compositions comprising thereof
KR101392808B1 (en) * 2011-12-30 2014-05-12 순천대학교 산학협력단 Antibacterial compositions containing plant extracts or fractions

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040010390A (en) * 2002-07-26 2004-01-31 가부시끼가이샤 롯데 Anti-influenza viral agent, the composition and the food containing the same
KR101164515B1 (en) * 2009-11-05 2012-07-11 한국 한의학 연구원 Composition for Prevention or Treatment of Disease Originated from Influenza Virus
KR101392808B1 (en) * 2011-12-30 2014-05-12 순천대학교 산학협력단 Antibacterial compositions containing plant extracts or fractions
KR20130095010A (en) * 2012-02-17 2013-08-27 재단법인 산청한방약초연구소 Natural anti-herpes virus agent and compositions comprising thereof

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018214641A1 (en) * 2017-05-24 2018-11-29 江苏省农业科学院 Use of agrimonia pilosa extract in preparation of drug for removing plant virus in tomato plants
EP3545765A4 (en) * 2017-05-24 2020-05-27 Jiangsu Academy of Agricultural Sciences Use ofagrimonia pilosa
US10813361B2 (en) 2017-05-24 2020-10-27 Jiangsu Academy Of Agricultural Sciences Use of agrimonia pilosa extract in preparation of drug for removing plant virus in tomato plants
KR101863267B1 (en) * 2017-09-05 2018-06-29 주식회사 바이오스톤 Disinfectant composition for controlling foot-and-mouth disease or avian influenza
KR20210071816A (en) * 2019-12-06 2021-06-16 울산대학교 산학협력단 Organic-inorganic emulsion composition for deodorization and antibacterial agent and fibrous mat having the composition
WO2023008594A1 (en) * 2021-07-26 2023-02-02 에이피알지 주식회사 Composition for prevention or treatment of coronavirus (sars-cov-2) infection, comprising agrimonia pilosa extract as active ingredient
CN115590873A (en) * 2022-10-31 2023-01-13 河南省农业科学院动物免疫学重点实验室(Cn) Application of baicalin in preparation of anti-pseudorabies virus medicine
CN115590873B (en) * 2022-10-31 2023-08-11 河南省农业科学院动物免疫学重点实验室 Application of baicalin in preparation of anti-pseudorabies virus medicine

Also Published As

Publication number Publication date
KR101647323B1 (en) 2016-08-11

Similar Documents

Publication Publication Date Title
KR101647323B1 (en) Virucidal composition containing natural products for avian inflenza virus
Hudson Applications of the phytomedicine Echinacea purpurea (Purple Coneflower) in infectious diseases
Fajimi et al. Herbal remedies in animal parasitic diseases in Nigeria: a review
KR102124592B1 (en) Hand-disinfectant composition for antibacterial and antivirus containing the extracts of natural material
Durlu-Ozkaya et al. Oleuropein using as an additive for feed and products used for humans
CN1173820A (en) Pharmaceutical composition for the treatment of herpes
Al-Obaidi Studies on antibacterial and anticancer activity of Nerium oleander extracts
CN1327770C (en) Sterilization composition containing carbendazim of multiple antimycin
CN111109304B (en) Disinfectant composition for improving pig immunity and antiviral ability and application method thereof
CN111493097A (en) Collective disinfectant for inhibiting viruses and pathogenic bacteria and preparation method thereof
CN101317904B (en) Uses of smoked plum extract in resisting virus, bacteria, mycoplasma or chlamydia of livestock and poultry
CN103054969B (en) Compound skin disinfectant and preparation method thereof
CN104430575A (en) Disinfectant for disinfecting wards and preparation method of disinfectant for disinfecting wards
CN102106347A (en) Cinnamaldehyde, eugenol, thymol and tannin compound bactericide
CN104886165A (en) Compound air disinfectant and preparation method thereof
Sundaramurthi et al. Effect of Tulsi (Ocimum sanctum) as a disinfectant for water treatment
CN1947750B (en) Traditional Chinese medicine for treating newcastle disease
KR101177182B1 (en) Artemisia Pill Contained with the Artemisia Alcoholic Extract Killing the 2009AH1N1 Influenza Viruses and the H9N2 Avian Influenza Viruses
KR20070106254A (en) Food additive and outside madicinal agents by producing wormwood-carbonized liquid
CN101390965A (en) Veterinary traditional Chinese herb medicine for treating livestock and poultry bacterial and viral infectious diseases and preparation method thereof
CN108653402A (en) giant knotweed skin antibacterial liquid
KR102408542B1 (en) Antibacterial and anti-coronavirus for companion animals, and manufacturing method thereof
Konaté et al. Qualitative analysis of phenolic compounds and antibacterial activity of trunk bark extracts of Anogeissus leiocarpus (dc.) guill. and perrot (combretaceae) traditionally used for the management of infectious diseases in village poultry
CN101757069A (en) Oral medical liquid for treating chicken mixed infection as well as preparation method and application thereof
KR100881033B1 (en) Composition comprising an extract of Celosia for preventing and treating animal disease caused by viruses

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20190723

Year of fee payment: 4